DESTINY TRIAL (Inspiron x Biomatrix)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 170 participants.

Also called NCT01856088

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 170 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01856088
Other papers using this trial's data
  • Metallic Limus-Eluting Stents Abluminally Coated with Biodegradable Polymers: Angiographic and Clinical Comparison of a Novel Ultra-Thin Sirolimus Stent Versus Biolimus Stent in the DESTINY Randomized Trial Cardiovascular therapeutics, 2015-12 DOI, PubMed 26352896

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Brazil (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01856088. Randomized; no masking; primary purpose treatment. Start 2013-05 (actual); primary completion 2014-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
DESTINY TRIAL (Inspiron x Biomatrix)
Intervention (Device)
Inspiron Stent
Intervention (Device)
Biomatrix Flex Stent
Lead sponsor
Scitech Produtos Medicos SA (class: industry)

Record details

Record id
cardio:ct-nct01856088
Content hash
011b49e6ab9f1a2e25013ac8d5f91edb51f745045f4e5b92fea49cec0283556f